Wave Life Sciences, Inc.: updates and filings

WVENASDAQHealthcare · Pharmaceutical Preparations

Price

$2.72

November 19, 2026Market cap $523M

What Ploutos Investor adds for Wave Life Sciences

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 11 fiscal years, from 2015
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 69 daysAround Jan 28, 2027 · for Q4 2026

last Oct 27, 2026next Jan 28, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Feb 26, 2026 latest annualOct 27, 2026 latest quarterly
  • Nov 18, 2026Officer or director change, shareholder vote
    Form8-K
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 27, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Oct 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 27, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 27, 2026Results of operations
    Form8-K
  • Oct 14, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Oct 14, 2026Annual meeting proxy statement
    FormDEF 14A
  • Aug 14, 2026Filing
    FormEFFECT
  • Aug 11, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Aug 10, 2026Filing
    Form15-12G
  • Aug 10, 2026Filing
    FormPOS AM
  • Aug 10, 2026Filing
    FormPOSASR
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS
  • Aug 10, 2026Filing
    FormS-8 POS

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 2, 2015.

The full analysis

What do Wave Life Sciences's filings show?

The filings are where every one of Wave Life Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.